Tarush Rustagi1, Ulas Yener2, Dukagjin Blakaj2, Kari Kenda2, Ehud Mendel2. 1. Ohio State University Wexner Medical Center and Arthur G. James Cancer Hospital, Columbus, Ohio, USA; Indian Spinal Injuries Centre, New Delhi, India. Electronic address: tarush.rustagi@gmail.com. 2. Ohio State University Wexner Medical Center and Arthur G. James Cancer Hospital, Columbus, Ohio, USA.
Abstract
BACKGROUND: Metastasis from melanoma carries poor prognosis and survival. Average life expectancy is estimated 4 to 6 months after diagnosis of skeletal metastasis. Comprehensive treatment, along with newer immunotherapies, has shown promising results. CASE DESCRIPTION: We report a case of long-term survival after metastasis to the brain and spine and discuss associated factors. CONCLUSIONS: Our report emphasizes the importance of regular and critical surveillance of the disease and aggressive surgical and medical management in melanoma. Published by Elsevier Inc.
BACKGROUND: Metastasis from melanoma carries poor prognosis and survival. Average life expectancy is estimated 4 to 6 months after diagnosis of skeletal metastasis. Comprehensive treatment, along with newer immunotherapies, has shown promising results. CASE DESCRIPTION: We report a case of long-term survival after metastasis to the brain and spine and discuss associated factors. CONCLUSIONS: Our report emphasizes the importance of regular and critical surveillance of the disease and aggressive surgical and medical management in melanoma. Published by Elsevier Inc.